Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2019/0015535 INTERNAL SURFACE ELECTRON BEAM-IRRADIATING DEVICE
An internal surface electron beam-irradiating device sterilizes the internal surface of a vial by irradiation with an electron beam. The internal surface...
2019/0015534 STERILIZED-LIQUEFIED GAS PRODUCING APPARATUS
The present invention provides a sterilized-liquefied gas producing apparatus including: a liquefied gas reservoir; a source-gas supplier that supplies a...
2019/0015533 Removal of Microorganisms from Fluid Samples Using Nanofiber Filtration Media
A method for removing microorganisms from liquid samples and a nanofiber containing liquid filtration medium that simultaneously exhibits high liquid...
2019/0015532 QUANTITATIVE PET IMAGING OF TISSUE FACTOR EXPRESSION USING 18F-LABLED ACTIVE SITE INHIBITED FACTOR VII
There is provided a positron-emitting 18F-labelled Factor VII for non-invasive PET imaging of tumor TF expression in humans. More specifically the invention...
2019/0015531 TRIFUNCTIONAL CONSTRUCTS WITH TUNABLE PHARMACOKINETICS USEFUL IN IMAGING AND ANTI-TUMOR THERAPIES
The present technology provides compounds, as well as compositions including such compounds, useful for imaging and/or treatment of a glioma, a breast cancer,...
2019/0015530 ISOTOPE PREPARATION METHOD
The present invention provides a method for the purification of .sup.227Th from a mixture comprising .sup.227Th and .sup.223Ra, said method comprising: i)...
2019/0015529 VISCOSITY AND STABILITY MODIFIED ULTRASOUND GEL
An ultrasound gel is provided for use with internal ultrasound imaging and/or therapy. The gel can have acoustic properties that can closely match a soft...
2019/0015528 ENGINEERED MICROBIAL POPULATION
Provided herein are genetically engineered bacteria that are native to a host insect microbiome. Further provided are methods of inducing RNA interference in...
2019/0015527 ADENO-ASSOCIATED VIRUS (AAV) CLADES, SEQUENCES, VECTORS CONTAINING SAME, AND USES THEREFOR
Sequences of novel adeno-associated virus capsids and vectors and host cells containing these sequences are provided. Also described are methods of using such...
2019/0015526 HYBRID MEMBRANE-COATED NANOPARTICLE COMPOSITES AND METHODS OF MAKING AND USING THE SAME
Disclosed herein are embodiments of nanoparticle composites that comprise covalently coupled stabilizing agent molecules that improve stability of the...
2019/0015525 ANTICANCER DRUG-CONTAINING PLANT VIRUS PARTICLES
Anticancer virus particles are described. Anticancer virus particles are filamentous or rod-shaped plant virus particle containing an anticancer agent within...
2019/0015524 PYRROLOBENZODIAZEPINE-ANTIBODY CONJUGATES
The present disclosure relates to the use of ADCs comprising anti-CD25 antibodies for in treating disorders characterized by the presence of CD25+ve cells.
2019/0015523 ELP FUSION PROTEINS FOR CONTROLLED AND SUSTAINED RELEASE
The present disclosure provides pharmaceutical formulations for sustained release, and methods for delivering a treatment regimen with a combination of...
2019/0015522 IMMUNOSTIMULATORY COMPOSITIONS AND METHODS OF USE THEREOF
Lipid conjugates for enhanced delivery of cargo to the lymph nodes are disclosed. The lipid conjugates typically include three domains: a lipophilic domain...
2019/0015521 TOPICAL DELIVERY OF THERAPEUTIC AGENTS USING CELL-PENETRATING PEPTIDES FOR THE TREATMENT OF AGE-RELATED MACULAR...
The present disclosure provides therapeutic agents for the treatment of age-related macular degeneration (AMD) and other eye disorders. One or more therapeutic...
2019/0015520 POLYMER CONJUGATES HAVING REDUCED ANTIGENICITY AND METHODS OF USING THE SAME
Disclosed herein are compositions and methods for reducing the antigenicity of molecules. The antigenicity of a molecule may be reduced or eliminated by...
2019/0015519 MMP-SENSITIVE TAXANE PRODRUG
The present invention harnesses the differential expression of membrane-type matrix metalloproteinases (MT-MMPs) between human solid tumours and normal tissues...
2019/0015518 DRUG DELIVERY COMPOSITIONS AND METHODS
One aspect of the present invention is directed to conjugates that comprise a linear polymer carrier, a linker and one or more drugs or imaging agents, as well...
2019/0015517 CONJUGATES OF QUATERNIZED TUBULYSIN COMPOUNDS
Compounds and compositions are disclosed in which a quaternized drug unit is linked to a targeting ligand unit from which a tertiary amine-containing drug is...
2019/0015516 ANTIBODY ADJUVANT CONJUGATES
The invention provides an immunoconjugate comprising an antibody construct which includes an antigen binding domain and an Fc domain, an adjuvant moiety, and a...
2019/0015515 GLUCOSE RESPONSIVE INSULIN DELIVERY COMPOSITIONS AND METHODS
Disclosed herein is a glucose-responsive insulin delivery system based on the interaction between the glucose-modified insulin and glucose transporters (GLUTs)...
2019/0015514 Use of a Polyanionic Composition
Disclosed herein is a use of a composition, comprising a non-toxic polyanionic material or a salt thereof to dissociate a polymeric membrane. In addition, a...
2019/0015513 PHARMACEUTICAL COMPOSITION COMPRISING RAPAMYCIN OR DERIVATIVE THEREOF
It is an object of the present invention to provide a pharmaceutical composition, which can suppress a reduction in the content of an active ingredient caused...
2019/0015512 PHARMACEUTICAL FORMULATIONS CONTAINING LIPOIC ACID DERIVATIVES
Pharmaceutical formulations containing lipoic acid derivatives and ion pairs thereof are described. The pharmaceutical formulations are useful in the treatment...
2019/0015511 Pre-Mixed, Ready-To-Use Pharmaceutical Compositions
Provided herein are ready-to-use premixed pharmaceutical compositions of nicardipine or a pharmaceutically acceptable salt and methods for use in treating...
2019/0015510 METHODS FOR MANUFACTURING PHTHALOCYANINE DYE CONJUGATES AND STABLE CONJUGATES
Provided are methods for manufacturing a conjugate containing a phthalocyanine dye, including methods that include one or more steps of preparing or producing...
2019/0015509 METHOD OF TREATING INFLUENZA A
Provided herein are methods for treating, reducing or preventing influenza A virus infection in a patient, as well as compositions and articles of manufacture...
2019/0015508 AGONIST ANTIBODIES THAT BIND HUMAN CD137 AND USES THEREOF
The present disclosure relates to, inter alia, compounds (e.g., antibodies, or antigen-binding fragments thereof) that bind to an epitope of CD137 and agonize...
2019/0015507 Combination of ACAT1 Inhibitor and Checkpoint Antibody for Treating Cancer
The present disclosure provides methods and compositions for the treatment of cancer using an ACAT1 inhibitor in combination with an immune checkpoint...
2019/0015506 A COMBINATION THERAPY USING REIC/Dkk-3 GENE AND A CHECKPOINT INHIBITOR
An object of the present invention is to provide a method of treating cancer using a checkpoint inhibitor in combination with REIC/Dkk-3 gene. The present...
2019/0015505 Method of Mediating Cardiovascular Hypertrophy and Perivascular Fibrosis Induced by Angiotensin II
Angiotensin II (AngII) has been strongly implicated in hypertension and its complications. Evidence suggests the mechanisms by which angiotensin II (AngII)...
2019/0015504 COMBINATION THERAPY WITH CD4 LYMPHOCYTE DEPLETION AND MTOR INHIBITORS
The invention provides methods for treating a malignant neoplastic cell proliferative disorder or disease, comprising administering to a subject in need...
2019/0015503 METHODS FOR THE PROGNOSIS AND TREATMENT OF ENDOMETRIAL CARCINOMA
The present invention relates to methods for predicting the survival time of patients from endometrial adenocarcinoma. The present invention also relates to...
2019/0015502 USE OF FLUORINATED CYCLIC DINUCLEOTIDES AS ORAL VACCINE ADJUVANTS
Disclosed is the use of fluorinated cyclic dinucleotides and pharmaceutically acceptable salts thereof as an adjuvant for the preparation of an oral vaccine....
2019/0015501 NUCLEIC ACID VACCINES
The invention relates to compositions and methods for the preparation, manufacture and therapeutic use ribonucleic acid vaccines (NAVs) comprising...
2019/0015500 INFLUENZA VIRUS VACCINES AND USES THEREOF
Provided herein are influenza hemagglutinin stem domain polypeptides, methods for providing hemagglutinin stem domain polypeptides, compositions comprising the...
2019/0015499 DNA VACCINE AGAINST VIRUS OF YELLOW FEVER
The present invention relates to vaccines of DNA that code for specific viral sequences. The DNA vaccines against yellow fever according to the invention are...
2019/0015498 Immune Enhancing Recombinant Dengue Protein
The invention relates to a method for preventing, ameliorating or treating disease caused by dengue virus in a subject in need thereof comprising administering...
2019/0015497 Virulence Attenuated Bacteria For Treatment Of Malignant Solid Tumors
The present invention relates to recombinant virulence attenuated Gram-negative bacterial strains for use in a method of treating a malignant solid tumor in a...
2019/0015496 Proteins and nucleic acids useful in vaccines targeting Klebsiella Pneumoniae
The present invention relates to proteins and nucleic acids derived from Klebsiella pneumonia as well as therapeutic and diagnostic uses of the proteins and...
2019/0015494 IDENTIFICATION OF CLASS I MHC ASSOCIATED GLYCOPEPTIDES AS TARGETS FOR CANCER IMMUNOTHERAPY
Provided are compositions that include one or more peptides, wherein each peptide is at least 8 amino acids long and has an amino acid sequence as set forth in...
2019/0015493 ADHERENT CANCER CELL LINE EXPRESSING A HEMATOLOGICAL TUMOR ANTIGEN
The present invention relates to a transduced cancer cell line stably expressing a leukemia tumor antigen, wherein the cancer cell line is cervical cancer...
2019/0015492 Novel Peptides and Combination of Peptides for Use In Immunotherapy Against Various Cancers
The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates...
2019/0015491 NEOEPITOPE RNA CANCER VACCINE
The present invention relates to an anticancer vaccine comprising polynucleotides or polypeptides, methods of treatment of cancer wherein such an anticancer...
2019/0015490 T CELL INDUCING VACCINE CONTAINING AN INTEREPITOPE SEQUENCE THAT PROMOTES ANTIGEN PRESENTATION
A long-chain peptide antigen includes a plurality of epitopes. An interepitope sequence located between two of the plurality of epitopes contains four to ten...
2019/0015489 METHODS AND MATERIALS FOR TREATING CANCER
This document provides methods and materials related to treating cancer. For example, methods and materials for using nucleic acid libraries to treat cancer...
2019/0015488 METHODS AND COMPOSITIONS USING LISTERIA FOR ENHANCING IMMUNOGENICITY BY PRIME BOOST
Provided herein are prime-boost regimens and materials used therein. The prime-boost regimens enhance the immune response to a target antigen. The vaccines...
2019/0015487 UNIVERSAL DONOR CELLS AND RELATED METHODS
Disclosed herein are universal donor stem cells and cells derived therefrom and related methods of their use and production. The universal donor stem cells...
2019/0015486 METHOD OF DETERMINING CELLULAR PROTEIN HOMEOSTASIS
The present invention provides assays and compositions to identify the risk of toxicity in a patient population with genotypic variations in specific proteins...
2019/0015485 METHOD FOR PREVENTING AND TREATING DIABETIC NEPHROPATHY
The present invention relates to the effect of plasminogen in the prevention and/or treatment of diabetic nephropathy. Compared with other existing drugs for...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.